Pfizer, Biontech announce vaccine candidate against Covid-19
Pfizer Inc and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against Covid-19 in participants without...
NIH & BARDA react to emergency use authorisation of Moderna Covid-19 vaccine by FDA
NIH and BARDA have reacted to the United States Food and Drug Administration's Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based...
Dr Reddy’s partnership for Sputnik V vaccine clinical trials in India
Dr. Reddy’s Laboratories has forged a partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support...
Indian Health Minister emphasizes on coordination for medical countermeasures
Indian Union Health Minister Dr. Mansukh Mandaviya emphasized on the importance of a formal global coordination mechanism for medical countermeasures and underscored the importance...
Happy news on war against Covid-19, Sputnik V vaccine to hit market in affordable...
Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF) has announced the cost of the Sputnik V vaccine for international markets will be less...
ChanRe, IARET throws light on Autoimmune diseases in awareness programme
An awareness programme on Autoimmune diseases & Lupus conducted by the Immunology & Arthritis Research & Education Trust (IARET) and ChanRe Rheumatology & Immunity...
Oramed Pharmaceuticals Inc starts Phase 3 Trial of Oral Insulin
Oramed Pharmaceuticals Inc announced that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for...
Cipla ups fight against Covid, launches ‘Covi-G’ for rapid antibody detection
Cipla Limited has inked a licensing agreement with a Belgium-based Multi G for the distribution of the latter's Covid-19 Rapid Antibody test kit.
As per...
GSK and Medicago commence Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Medicago and GSK have announced the beginning of Phase 2/3 clinical trials of plant-derived vaccine candidate for Covid-19.
The study is being done to assess...
Chanre Update conference focuses on allergies & autoimmune diseases
The 21st Chanre Update conference that focused on allergies & autoimmune diseases drawn a huge attention from the medical practitioners across the segment.
In the...
